EUVIMEDEUVIMED entdecken
Open Access · CC BY-SA 4.0

Revealing the Potency of Camelia sinensis and Serenoa repens as Purinoreceptor Inhibitor for Benign Prostatic Hyperplasia Treatment through in Silico Study

Mega Memory Rahasa Putra, Kurnia Penta Seputra

Journal of Biomedicine and Translational Research · 2024

DOI: 10.14710/jbtr.v10i2.21211 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biomedicine and Translational Research, 2024. Verfasst von Mega Memory Rahasa Putra und 1 weiteren Autor:innen. Die Arbeit nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-SA 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Benign prostatic hyperplasia (BPH) is the most common prostate disease in elderly men that leads to a significant deterioration in patients' quality of life (QoL). Pharmacological therapy of 5-alpha reductase inhibitor and alpha adrenoreceptors blocker often causes several side effects that decrease the QoL, so it is necessary to develop a new treatment for BPH. Purinoreceptor is a novel receptor that can inhibit electrically evoked nerve-mediated contractions in the prostate. Tea leaves (Camellia sinensis) and Saw palmetto (Serenoa repens) are herbs that have potential as alternative therapies for BPHObjective: to reveal the mechanism of Camellia sinensis and Serenoa repens through purinoreceptor and the other receptorsMethods: Structures of active compounds were extracted from PubChem and protein from PBD. The active compounds Camellia sinensis and Serenoa repens to the target protein purinoreceptors, 5-alpha-reductase, and alpha adrenoreceptors was evaluated in silico using a docking server with Finasteride dan Tamsolusin as a control. Molecular docking method using dockingserver application.

Results

Epigallocatechin gallate only compound that has potency in blocking purinoceptors and 5-alpha-reductase. Capric acid, Caprylic acid, Lauric acid, Linoleic acid, and Myristic acid have the potential to bind to alpha adrenoreceptor ligands.

Conclusion

Camellia sinensis have potential and effects as alternative therapies in benign prostatic hyperplasia on the target protein purinoreceptors, 5-alpha-reductase, and alpha adrenoreceptors. But, Serenoa repens have potential only through alpha adrenoreceptors.

Zitieren

APA

Putra, M. M. R., & Seputra, K. P. (2024). Revealing the Potency of Camelia sinensis and Serenoa repens as Purinoreceptor Inhibitor for Benign Prostatic Hyperplasia Treatment through in Silico Study. Journal of Biomedicine and Translational Research. https://doi.org/10.14710/jbtr.v10i2.21211

Vancouver

Putra MMR, Seputra KP. Revealing the Potency of Camelia sinensis and Serenoa repens as Purinoreceptor Inhibitor for Benign Prostatic Hyperplasia Treatment through in Silico Study. Journal of Biomedicine and Translational Research. 2024. doi:10.14710/jbtr.v10i2.21211

BibTeX
@article{Putra2024,
  author = {Putra, Mega Memory Rahasa and Seputra, Kurnia Penta},
  title = {Revealing the Potency of Camelia sinensis and Serenoa repens as Purinoreceptor Inhibitor for Benign Prostatic Hyperplasia Treatment through in Silico Study},
  journal = {Journal of Biomedicine and Translational Research},
  year = {2024},
  doi = {10.14710/jbtr.v10i2.21211}
}
Kostenlos starten →